Skip to content
Recovery & Performance PeptidesRecovery research and practical context

For years, men and women have used peptide therapy as a way to boost their immune system and stay healthy. Thymosin Alpha 1, also known as the “immune enhancing peptide,” helps the body fight against dangerous microorganisms that could lead to infection.

Learn how to boost your immune system naturally. →

At Amy Brenner, MD & Associates we offer different types of peptides to help your immune system thrive, and we’ve seen first-hand their amazing benefits. Keep reading for more information on peptides and immunity and how Thymosin Alpha 1 works to benefit your overall wellness goals. 

How does Thymosin Alpha 1 work? 

Thymosin Alpha 1 (TA1) is naturally produced in your thymus gland and creates disease-fighting T-cells for your immune system. As you age, thymosin production decreases, making you more vulnerable to infections, autoimmune diseases, and inflammation—that’s where TA1 peptide therapy comes in. 

TA1 is an “immune-enhancing” peptide and offers proven benefits including:

  • Exhibits antibacterial and antifungal properties
  • Increases vaccine effectiveness
  • Enhances the function of certain immune cells
  • Helps eradicate the unhealthy cells and stop infection or cancer growth
  • Strengthens the immune system

💡Note: You will need a prescription to receive TA1 peptides. If you’re in the Cincinnati area, our team at Amy Brenner, MD & Associates can determine whether TA1 is right for you and help you begin treatment. 

Learn more about peptides and immunity from Amy Brenner, MD & Associates

Let our health experts help you stay healthy and well throughout the flu season and beyond. As a medspa and medical practice, we are uniquely equipped with the ability to not only boost your overall health, but also help you enhance your outer beauty with aesthetic treatments.  

We’re here to offer a warm, friendly environment while providing the highest quality aesthetic treatments and wellness plans to help you look great and feel great. No matter what, we will stick with you throughout your entire journey, because your goals are our goals. 

Get started today by using our virtual consultation tool or scheduling an appointment. 

Virtual Consultation Schedule an Appointment 

CONNECTED / MODULES

Post-session references

Selected from shared article topics. Source links are retained where available.

01

Handling & safety lane

Source-derived education, not individual medical guidance or an instruction to dose.

DOSAGE SOURCE

Thymosin Alpha-1 Dosage

For reference purposes, we relate a sample thymosin alpha-1 dosage protocol that may be administered to achieve inflammation reduction in subjects [2]:
SIDE EFFECTS

Risks & Side Effects

Thymosin Alpha-1 has generally demonstrated a favorable safety profile in published clinical trials. Reported adverse effects include: Injection-site pain or redness Mild fatigue Headache Nausea Muscle aches Fever Mild skin irritation Hypersensitivity reactions (rare) Because Thymosin Alpha-1 modifies immune function, caution should be exercised in individuals receiving immunosuppressive therapy or those with autoimmune diseases. Overall, published studies have reported relatively few serious adverse events compared with many immunomodulatory medications.
03

Evidence cooldown

Research context and source excerpts for a slower second read.

RESEARCH

Researchers Cited in This Article

The researchers below authored or co-authored publications cited in this article. Listing them here identifies sources; it does not mean they wrote, independently reviewed, sponsored, or endorsed this PeptideDosages.com article. The site author is identified in the article byline.

RESEARCH

Future research

Peptides have huge therapeutic value. Significant research has taken place over the years. It has successfully treated a wide range of diseases. It’s also used in aesthetic treatments. Many people feel comfortable in using this safe and natural approach to their health. There’s great potential for this market to increase. Investments into this area of research seem positive. Continuous support from the government and investors can increase COVID research. With the success of this treatment, there’s a need to make more of them available. Phase 3 trial in hepatitis C is still in progress. The same applies to phase 2 in hepatitis B. There are also efforts underway to improve oral availability. To make it more permeable for the GI tract.

05

Product & matchup locker

Linked catalog and comparison files.

Comparison

Study Dosage Versus Personalized Medical Advice

Study dosage answers the question: “What did researchers evaluate?” It does not answer: “What should a specific person take?” Personal medical decisions depend on diagnosis, indic…